Nasal drug delivery system: Opportunities and challenges

Indian Drugs

Volumn 45, Issue 5, 2008, Pages 345-353

  Shaji, J ^a   Marathe, S W ^a  

^a PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

Author keywords

Microspheres; Nasal drug delivery; Nasal vaccines

Indexed keywords

ALPRENOLOL; BACTERIAL VACCINE; BARBITURIC ACID DERIVATIVE; CHITOSAN; CROMOGLYCATE DISODIUM; DNA VACCINE; ESTRADIOL; FLUNISOLIDE; GENTAMICIN; GLYCERYL TRINITRATE; HISTAMINE; HYDRALAZINE; INSULIN; ISOPRENALINE; LEUKOTRIENE D4; LIPOSOME; MANNITOL; METOPROLOL; MICROSPHERE; NALOXONE; NOSE SPRAY; PEPTIDE FRAGMENT; PROGESTERONE; PROPRANOLOL; PROSTAGLANDIN E1; ROSE BENGAL; TERBUTALINE; TESTOSTERONE; TETANUS TOXIN; UNINDEXED DRUG;

AEROSOL; AREA UNDER THE CURVE; CENTRAL NERVOUS SYSTEM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DECOMPOSITION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG UPTAKE; ENZYMATIC DEGRADATION; FUNCTIONAL ANATOMY; HUMAN; INFECTION PREVENTION; LIPOPHILICITY; METERED DOSE INHALER; MOLECULAR WEIGHT; NONHUMAN; NOSE CAVITY; NOSE MUCOSA; NOSE SECRETION; PARTITION COEFFICIENT; PH; PHYSICAL CHEMISTRY; REVIEW; SUSPENSION;

EID: 77954899309     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. ChienY.W., Su K.S.E. and Chang S.F.: Nasal Systemic Drug Delivery, Marcel Dekker, New York, 1989.
2. Chien Y.W., Chang S.F.: Treatise on Controlled Drug Delivery: Nasal Drug Delivery, Ed. Agis Kydonieous, 1991, Marcel Dekker; 423-463.
3. Chien Y.W.: Novel Drug Delivery System: Nasal Drug Delivery and Delivery Systems, Marcel Dekker, 1992,229-268
4. Merkus F.W.H.M. And Verhoef J.C.: Nasal Drug Delivery: Trends and perspectives in Encyclopedia of Pharmaceutical technology Volume 10,Ed. James Swarbrick and James C. Boylan, Marcel Dekker, New York, 1994, 191-221.
5. Stratford Jr R. E. and Lee V.H.L: Aminopeptidase activity in homogenates of absorptive mucosa in the albino rabbit: implications in peptide delivery, Int. J. Pharm., 30, 1986,73-82
6. Schipper N.G.M., Verhoef J., Romeijn S.G., Merkus F.W.H.M.: Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning, J. Control Release, 21,1992,173-186.
7. McMartin C., Hutchinson L.E.F., Hyde R. and Peters G.E.: Analysis of structural requirements for the absorption of drug and macromolecules from the nasal cavity, J. Pharm Sci., 76, 1987,535-540.
8. Fisher A. N., Brown K., Davis S.S., Parr G. D. and Smith D.F.: The effect of molecular size on the nasal absorption of water soluble compounds in the albino rat; J. Pharm. Pharmacol. 39; 357-362(1987)
9. Chien Y.W. (ed): Transnasal Systemic Medication Elsvier,Amsterdam,1985.
10. Duchateau G.S.M.J.E, Zuidema J., and Merkus F.W. H. M.:Bioavailability of propranolol after oral, sublingual and intranasal administration ;Pharm Res3, 1986,108-111.
11. Duchateau G.S.M.J.E., Zuidema J., Albersand W.M., Merkus F.W.H.M.: Nasal absorption of aiprenolol and metoprolol, Int. J. Pharm, 34, 1986,131-136.
12. Carbo D.C., Huang Y.C. and Chien Y.W.: Nasal delivery of progestational steroids in ovariectomized rabbits: I Effect of penetration hydrophilicity, Int. J. Pharm, 50, 1989,253-260.
13. Gibson R.E. and Olanoff L.S.: Physicochemical determinants of nasal drug absorption, J. Control. Release, 6, 1987, 361-366
14. Harai S., Yashiki R., Matsuzawa T. and Mima H.: Absorption of drug from the nasal mucosa of rat; Int. J. Pharm.,7, 1981,317-325.
15. Sarkar M.A.: Drug metabolism in the nasal mucosa, Pharm. Res.9, 1992,1-9.
16. Wheatly M.A., Dent J., Wheeldom E.B. and Smith P.L.: Nasal drug delivery: An in-vitro characterization of transepithelial electrical properties and fluxes in the presence or absence of enhances, J.Control.Release 8, 1988, 167-177.
17. Fisher A. N., Brown K., Davis S.S., Parr G.D. and Smith D. A.: Nasal absorption of sodium cromoglycate in the albino rat, J. Pharm. Pharmacol. 37, 1985,38-41. (Pubitemid 15189944)
18. Vandenberg M.P., Verhoef J.C., Rameijn S.T., Mercus F.W.H.M.: Uptake of estradiol or progesterone into CSF following intranasal and intravenous delivery in rats, Euro. J. Pharm and Biopharm.,58, 2004,131-135.
19. Yu C.D., Jones R.E. and Henesion M.: Cascade impactor method for the droplet size characterization of a metered dose nasal spray, J. Pharm. Sci. 73,, 1984,344-348.
20. Hardy J.G., Lee S.W. and Wilson C.G.: Intranasal drug delivery by spray and drop, J. Pharm. Pharmacol., 37, 1985,294-297.
21. Gonda I. and Gipps E.: Model of disposition of drugs administered into the human nasal cavity, Pharm.Res.7, 1990,69-75 (Pubitemid 20115802)
22. Corbo D. C., Huang Y.C. and Chien Y.W.: nasal delivery of progestational steroids in a ovariectomized rabbits: I Progesteron-comparison of pharmacokinetics with intravenous and oral administration, Int J. Pharm. 46, 1988,133-140.
23. Illum L., Farraj N., Critchley H. and Davis S.S.: Nasal administration of gentamicin using a novel microsphere delivery system, Int. J. Pharm., 46, 1988,261-165.
24. Bjok E. and Edman P.: Degradable starch microspheres as a nasal delivery system for insulin, Int. J. Pharm., 47,1988,233-238.
25. Illum L., Jorgensen H., Bisgaard H., Krogsgaard O. and Rossing N.: Bioadhesive microspheres as a potential nasal drug delivery system: Int. J. Pharm. 39, 1987, 189-199.
26. Farraj N.F., Johansen B.R., Davis S.S. and Illum L.: Nasal administration of insulin using bioadhesive microspheres as a delivery system, J.Control. Release, 13,1990, 253-261.
27. Lau S.K., Huang K. J., Chau H. V.: Preparation of desmopressin containing liposomes for intranasal delivery, J. Control. Release 70,2001,375-382.
28. Nagai T., Nishimoto Y., Nambu N., Suzuki Y. and Sekine K.: Powder dosage form of insulin for nasal administration, J. Control Release,1, 1984,15-22.
29. Lognecker J.P., Moses A.C., Flier J.S., Silver R.D., Careyand M.C., Dubov E. J.: Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep; J. Pharm.Sci. 76, 1987,351-355
30. Deurloo M.J.M., Hermens W.A.J.J., Romeyn S.G., Verhoef J.C. and Merkus F.W.H.M.: Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate(STDHE) in rabbits and rats, Pharm. Res.,6,1989,853-856.
31. 2 EDTA, and Aprotinin on rectal, nasal and buccal insulin delivery, Pharm.Res., 5, 1988,305-308
32. Illum L., Farraj N.F., Critchley H., Johansoan B.R. and Davis S.S.:Nasal administration of gentamicin using a novel microsphere delivery system, Int.J. Pharm, 46, 1988, 261-265.
33. Duchateau G.S.M.J.E., Zuidema J.and Bosseleur S.W. J.: Influence of some surface active agents on nasal absorption in rabbits, Int. J. Pharm, 39, 1987,87-92.
34. Hersey S.J. and Jackson R. T.: Effect of bile salt on nasal permeability in-vitro, J. Pharm Sci. 76, 1987, 876-879.
35. Raechs S.C., Snadow J., Wirth K. and Merkle H.P.: The adjuvant effect of Bacitracin on nasal absortption of Gonadorelin and Buserelin in rats, Pharm Res., 5,1988, 689-693.
36. Hermens W.A.J.J., Hooymans P.M., Verhoef J.C. and Merkus F.W.H.M.: Effects of absorption enhancers on human nasal tissue ciliary movement in vitro,Pharm Res., 7,1990,144-146.
37. Jain N.K.: Progress in controlled and Novel drug delivery systems: Engg. Commensal bacteria as novel drug delivery system,CBS Publishers and Distributors, New Delhi,2004,455-457.
38. Hermens W.A.J.J., Deurloo M. J. M., Romeijn S.G, Verhoef J. C., Merkus F.W.H.M.: Nasal absorption enhancement of 17-β-Estradiol-β- Cyclodextrin in rabbits and rats by Dimethyl-β-cyclodextrin in rabbits and rats, Pharm Res 7, 1990,500-503.
39. Schipper N.G.M., Hermens W.A.J.J., Romeijn S.G., Verhoef J. C. and Merkus F.W.H.M.: Nasal absorption 17-beta-estradiol and progesterone from a dimethyl-cyclodextrin inclusion formulation in rats, Int J. Pharm, 64, 1990,61-66.
40. Artursons A., Lindmark T., Davis S.S., Illum L.,: Effect of chitosan on the permeability of monolayers of intestinal epithelial cells(caco-2), Pharm Res.,11,1994,21-32.
41. Dodane V., Khan M.A., Merwin J.R.,: Effect of chitosan on epithelial permeability and structure, Int. J. Pharm, 182,1999,21-32. (Pubitemid 29229791)
42. Morimoto K., Morisaka K. and Kamada A.: Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel, J. Pharm. Pharmacol., 37, 1985, 134-136.
43. Hussain A.A., Harai S. and Bawarsh R.: Nasal absorption of Propranolol in rats, Pharm Sci., 68, 1979,1196-1198
44. Leither V.M., Guggi D., Krauland A.H., Bernkop-Schnurch A.: Nasal delivery of human growth hormone in-vitro and in-vivo evaluation of thiomer/glutathione microparticles delivery systems, J. Control. Release 100, 2004,87-95.
45. Sinha V.R., Trehan A.: Biodegradable microspheres for protein delivery, J.Control Release, 90(3),2003,261-280.
46. Takenaga M., Serizawa Y., Azechi Y., Ochiai A., Kasaku Y., Igarashi R., Mizushima Y.,: Microparticle resins as a potential nasal drug delivery system for insulin, J. Control Release, 52(1-2),1998,81-87.
47. Su K.S.E., Campanale K.M. and Gries C.L.: Nasal drug delivery of a Quaternary Ammonium compound:Clofilium Tosylate, J. Pharm Sci., 73, 1984,1251-1254.
48. Callens C., Adrianes E., Dierckens K., Remon J.P.: Toxicological evaluation of a bioadhesive nasal powder containing starch and Carbopol 974p on rabbit nasal mucosa and slug mucosa, J. Control. Release 76,2001,81-91.
49. Hussain A.A., Kimura R. and Huang C.H.: Nasal absorption of naloxone and buprenorphine in rats, J. Pharm Sci., 73, 1984,233-237. (Pubitemid 14038848)
50. Hussain A.A., Hirai S. and Bawarshi R.: Nasal absorption of natural contraceptive steroids in rats- progesterone absorption, J.Pharm Sci, 70, 1981,466-467.
51. Hussain A.A., Kimura R. and Huang C.H.: Nasal absorption of testosterone in rats; J. Pharm Sci, 73, 1984,1300-1301.
52. Daugherty A. L., Liggitt H.D., McCabe J.G., Moore J. A. and Patton J. S.: Absporption of recombinant methionyl-human growth hormone (Met-hGH) from rat nasal mucosa, Int. J.Pharm., 45,1988,197-206.
53. Singh M., Briones M., O'Hagun D.J.: A novel bioadhesive intranasal delivery system for inactivated influenza vaccine, J. Controlled Release 70,2001,267-276.
54. Illum L.,: Nasal drug delivery-Possibilities, Problems and Solutions, J Control Release, 87,2003,187-198.